BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Atonarp and IMA Life Enter Supply Agreement For Pharmaceutical Lyophilization Applications

  The AMS solution was developed in collaboration between IMA Life, Atonarp and a major pharma company with purpose-built quantitative instrumentation for the application of freeze-drying and aseptic processing.

  November 6, 2017

   · 

  3 min read
• Business

  Rexahn Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update

  Rexahn’s cash and investments totaled approximately $23.2 million as of September 30, 2017, compared to approximately $20.3 million as of December 31, 2016.

  November 6, 2017

   · 

  9 min read
• Pharm Country

  Egalet Announces ARYMO ER Added to Large Payer Medicare Part D Formulary

  Egalet today announced that a large payer will provide coverage of ARYMO ER (morphine sulfate) extended-release tablets for oral use -CII for its Medicare Part D members.

  November 6, 2017

   · 

  17 min read
• Business

  Catalent Reports First Quarter Fiscal 2018 Results

  First quarter 2018 revenue of $543.9 million increased 23% as reported and 22% in constant currency from $442.2 million reported in the first quarter a year ago.

  November 6, 2017

   · 

  26 min read
• Policy

  Collegium Notified that the FDA Will Not Meet PDUFA Goal Date for sNDA for Xtampza ER

  Collegium CEO says the FDA hasn’t requested any additional scientific information or data.

  November 6, 2017

   · 

  8 min read
• Biotech Beach

  ChemDiv’s Discovery Chemistry Platform to Help Advance Tri-Institutional Therapeutics Discovery Institute Programs ChemDiv logo

  This collaboration with ChemDiv is aimed at assisting Tri-I TDI investigators with developing therapies across multiple therapeutic areas.

  November 6, 2017

   · 

  1 min read
• Business

  Summit Announces Signing of Revenue Sharing Agreement With the Wellcome Trust for CDI Antibiotic Ridinilazole

  Entering revenue share in accordance with terms of prior Wellcome Trust funding award agreement.

  November 6, 2017

   · 

  6 min read
• Drug Development

  Lupus Research Alliance Prompted Stelara Study for Lupus - Results Show Potential for New Treatment Option

  Based on the positive results from the Phase II study, Janssen announced plans to test Stelara in a future Phase III program.

  November 6, 2017

   · 

  3 min read
• Bio NC

  Panaceutics to Participate in Personalized Medicine Conference at Harvard Medical School - November 14-16th

  Panaceutics today announced that it has joined the Personalized Medicine Coalition and has been invited to participate in the 13th Annual Personalized Medicine Conference on November 14th through 16th, hosted by Harvard Medical School in Boston, MA.

  November 6, 2017

   · 

  2 min read
• Business

  Takeda, Lundbeck and Advocate Health Care Research Study Aims to Enhance Patient-Provider Engagement in Major Depressive Disorder Treatment Using Digital Technology

  Takeda, Lundbeck U.S. and Advocate Health Care today announced a collaboration focusing on the use of digital technology to support people living with depression.

  November 6, 2017

   · 

  6 min read